| 1 | CNM2, DNM2
|
| Clinical, Electrophysiology, and Pathology Features of Dynamin Centronuclear Myopathy: A Case Report and Review of Literature.
|
| Verma S, Balasubramanian SB.
|
| J Clin Neuromuscul Dis 18(2):84-88.
2016
|
| 2 | CNM2, DNM2
|
| Clinical, pathological and genetic characteristics of autosomal dominant inherited dynamin 2 centronuclear myopathy.
|
| Liu X, Wu H, Gong J, Wang T, Yan C.
|
| Mol Med Rep 13(5):4273-8. doi: 10.3892/mmr.2016.5047.
2016
|
| 3 | CNM2, DNM2
|
| Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
|
| Romero NB, Bevilacqua JA, Oldfors A, Fardeau M.
|
| Neuromuscul Disord 21(2):148; author reply 148-9. No abstract available.
2011
|
| 4 | CNM2, DNM2
|
| Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
|
| Liewluck T, Lovell TL, Bite AV, Engel AG.
|
| Neuromuscul Disord 20(12):801-4.
2010
|
| 5 | CNM2, DNM2
|
| A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
|
| Durieux AC, Vignaud A, Prudhon B, Viou MT, Beuvin M, Vassilopoulos S, Fraysse B, Ferry A, Lainé J, Romero NB, Guicheney P, Bitoun M.
|
| Hum Mol Genet 19(24):4820-36. Epub 2010 Sep 21.
2010
|
| 6 | CNM2, DNM2
|
| Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
|
| Bitoun M, Bevilacqua JA, Prudhon B, Maugenre S, Taratuto AL, Monges S, Lubieniecki F, Cances C, Uro-Coste E, Mayer M, Fardeau M, Romero NB, Guicheney P.
|
| Ann Neurol 62(6):666-70.PMID: 17932957 2007
|
| 7 | DNM2, MYCN, CNM2
|
| Mutations in dynamin 2 cause dominant centronuclear myopathy.
|
| Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, Martin JJ, Laporte J, Lochmuller H, Beggs AH, Fardeau M, Eymard B, Romero NB, Guicheney P.
|
| Nat Genet 37(11):1207-9. Epub 2005 Oct 16. 2005
|